2012 Round-UpMultiple sclerosis: new measures to monitor the disease
References (13)
- et al.
Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial
Lancet Neurol
(2012) - et al.
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
Lancet
(2012) - et al.
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Ann Neurol
(2011) - et al.
2010 McDonald criteria for diagnosing pediatric multiple sclerosis
Ann Neurol
(2012) - et al.
Revised diagnostic criteria for neuromyelitis optica
Neurology
(2006) - et al.
Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis
Neurology
(2010)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2013 Elsevier Ltd. All rights reserved.